RECENT NEWS

Centred on the theme, 'Innovations in Dementia Research: What the Future Holds for Dementia Clinical Practice', Alzheimer’s Research UK's conference is taking place at The Royal College of Physicians on 14 October.

Post-pandemic NHS backlogs threaten the health and wellbeing of thousands of doctors, as well as their patients, the General Medical Council (GMC) has warned in a new report.

The first new mesothelioma treatment to be approved in nearly 15 years is to be made available for hundreds of patients with aggressive respiratory cancer.

Women are more likely to die within five years of having elective surgery to repair a weakening in the wall of the aorta or need repeat surgery, according to a recent Rutgers study.

A condition linked to thousands of UK deaths has been significantly reduced by healthcare professionals at County Durham and Darlington NHS Foundation Trust, with the help of a new care model, supported by specialist nurses, and developed in partnership with NHS technology provider C2-Ai.

The UK government has announced that NHS staff in England will get a pay increase of at least £1,400 for 2022-23, equal to a 4% uplift (far below the rate of inflation), while the pay increase will be taken out of the existing NHS budget. The news received a backlash from leading professional bodies.

Coloplast UK and Ireland is joining forces with the UK’s three largest stoma charities to co-host a first-of-its-kind relay to Parliament to issue a new ‘Calls to Action’ statement (launched Wednesday 20 July).

A host of world-class speakers will lift the curtain on cutting-edge technologies which have been developed during COVID-19 and how advancements can be made within the surgical profession in a post-pandemic world.

In response to strong support for the adoption of Global Trade Item Numbers (GTINs) in healthcare, the MHRA have stated their intention to authorise the use of GS1 standards to uniquely identify medical devices and enhance patient safety.

Children born to mothers with polycystic ovary syndrome (PCOS) have an increased risk of developing infections, allergies and other childhood illnesses by the age of 13, according to the largest study to investigate this.

The North East Innovation Lab has played a key role in a successful study to develop a new biosensor which could be used in COVID-19 diagnostic tests.

2. Braun Medical has become the official medical and welfare sponsor for the most significant physical gathering of transplant patients since 2019.

The Health and Social Care Secretary Steve Barclay has appointed Dr. Henrietta Hughes OBE as the first ever Patient Safety Commissioner for England.

The head of England’s NHS has praised the exceptional efforts and skill of health service staff across the country, after being presented the George Cross by Her Majesty The Queen at Windsor Castle.

Research carried out by the Health Foundation’s REAL Centre finds that the next decade will see increases in demand for services from rising levels of chronic disease and a rapidly ageing population – putting pressure on hospital services that are already stretched with bed occupancy rates of close to 90%.

The RCN has responded to Prime Minister Boris Johnson’s resignation, calling on new Health Secretary Steve Barclay to prioritise making the right decision on the next NHS pay award.

Patients across the UK will benefit from a supercharged clinical research system, backed by £175 million of dedicated investment, which will save lives across the country.

Traumatic brain injury may lead to reduced brain size in some children and teenagers which can be linked to cognitive problems, a new study shows.

High dose inhaled nitric oxide gas (iNO) is a safe and effective respiratory therapy for pregnant women hospitalised with severe COVID-19 pneumonia, resulting in a more rapid weaning from supplemental oxygen and reduced length of hospital stay, according to a research team led by Massachusetts General Hospital (MGH).

Gas control specialists BPR Medical and Medclair, a leading Sweden-based specialist in safe nitrous oxide use, have signed an agreement that gives BPR exclusive rights to supply Medclair’s mobile nitrous oxide conversion technology in the UK and Ireland.